FDA Will Cooperate With OTC Drug Industry To Address Labeling Questions
This article was originally published in The Tan Sheet
Executive Summary
FDA will work cooperatively with industry to address complications that may arise from the final rule on standardized OTC labeling announced March 11, Commissioner Jane Henney, MD, told the Nonprescription Drug Manufacturers Association annual meeting in Boca Raton, Fla. March 12 (see related stories, pp. 4-10). NDMA is being renamed the Consumer Healthcare Products Association.
You may also be interested in...
Drug Facts Label Should Be Required On Immediate Package – ONP’s Ganley
Allowing the sale of OTC drugs in packages without Drug Facts labels on the immediate container poses risks for consumers, FDA Office of Nonprescription Products Director Charles Ganley says
Drug Facts Label Should Be Required On Immediate Package – ONP’s Ganley
Allowing the sale of OTC drugs in packages without Drug Facts labels on the immediate container poses risks for consumers, FDA Office of Nonprescription Products Director Charles Ganley says
Drug Facts Label Should Be Required On Immediate Package – ONP’s Ganley
Allowing the sale of OTC drugs in packages without Drug Facts labels on the immediate container poses risks for consumers, FDA Office of Nonprescription Products Director Charles Ganley says